The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genetic heterogeneity of KRAS-mutated NSCLC: Co-occurrence of potentially targetable aberrations and evolutionary background.
 
Matthias Scheffler
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis; Roche Pharma AG
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
 
Michaela A. Ihle
No Relationships to Disclose
 
Rebecca Hein
No Relationships to Disclose
 
Sabine Merkelbach-Bruse
Honoraria - AstraZeneca; Pfizer; Roche
Research Funding - Merck Serono; Novartis; Roche
 
Johannes Braegelmann
No Relationships to Disclose
 
Andreas H. Scheel
Honoraria - Novartis
Consulting or Advisory Role - Novartis
 
Sebastian Yves Friedrich Michels
Honoraria - Boehringer Ingelheim; Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Frank Ueckeroth
No Relationships to Disclose
 
Anna Eisert
No Relationships to Disclose
 
Leonie Gogl
No Relationships to Disclose
 
Rieke Frank
No Relationships to Disclose
 
Rieke Nila Fischer
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb
 
Sophia Koleczko
No Relationships to Disclose
 
Carsten Schaepers
No Relationships to Disclose
 
Anna Kostenko
No Relationships to Disclose
 
Florian Kron
No Relationships to Disclose
 
Martin Hellmich
No Relationships to Disclose
 
Martin L. Sos
Consulting or Advisory Role - Blackfield; My Cancer Genome
 
Reinhard Buettner
Consulting or Advisory Role - Lilly; Novartis; Roche/Genentech
 
Juergen Wolf
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Research Funding - Bayer; Boehringer Ingelheim; Novartis; Pfizer; Roche